CONTACT

A Lettertype grootte verkleinen. A Lettertype grootte resetten. A Lettertype grootte vergroten.


Wachtwoord vergeten?
MARTINE VERCAMMEN

dr. Martine Vercammen

Laboratoriumgeneeskunde
Contactgegevens op ziekenhuiswebsite

Gebruik de knoppen om de artikels, publicaties en presentaties van deze auteur te raadplegen.

Artikels

Geen resultaten gevonden

Publicaties

The impact of Covic-19 pandemic on autoimmune diagnostics in Europe: a lesson to be learned.

28/10/2021
Vercammen, Martine
Laboratoriumgeneeskunde
Autoimmun Rev 2021, Oct 28:102985. doi: 10.1016/j.autrev.2021.102985. Online ahead of print.PMID: 34718167

Kappa Free Light Chains Is a Valid Tool in the Diagnostics of MS: A Large Multicenter Study.

01/01/2019
Vercammen, Martine Vanopdenbosch, Ludo
Laboratoriumgeneeskunde
Multiple Sclerosis Journal, 2019, DOI: 10.1177/1352458519845844

International consensus on ANA patterns (ICAP): inbedding in het Nederlandse taalgebied.

01/01/2018
Vercammen, Martine
Laboratoriumgeneeskunde
Laboratoriumgeneeskunde 2018;3:17-26

Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.

01/01/2018
Vercammen, Martine
Laboratoriumgeneeskunde
Leukemia 2018; 32(8):1815-1818

Antigen excess detection by automated assays for free light chains.

01/01/2018
Vercammen, Martine
Laboratoriumgeneeskunde
Clin Chem Lab Med 2018; 56(9) e235-e238. doi: 10.1515/cclm-2017-0977

Analytical performance of the single well titer function of NOVA View: good enough to omit ANA IIF titer analysis?

01/01/2018
Vercammen, Martine
Laboratoriumgeneeskunde
Clin Chem Lab Med 2018; 56(11):258-261.

Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment.

01/01/2018
Vercammen, Martine
Laboratoriumgeneeskunde
Ann Rheum Dis 2018 Sept 5; pii: annrheumdis-2018-214078. doi: 10.1136/annrheumdis-2018-214078. [Epub ahead of print]

Presentaties

‘ICAP questionnaire: Current laboratory and clinical practices in reporting and interpreting ANA IIFA patterns.’

06/09/2021
Vercammen, Martine
Dresden, Germany

An international survey on methodological aspects of anti-nuclear antibody testing by indirect immunofluorescence analysis: current practices for method verification.

07/09/2021
Vercammen, Martine
Dresden, Germany

Feasibility of harmonization in automated ANA IFA testing: results of the Benelux Multicenter study 2019.

20/05/2021
Vercammen, Martine
Athens, Greece

An international survey on methodological aspects of anti-nuclear antibody testing by indirect immunofluorescence analysis: current practices for internal quality control.

20/05/2021
Vercammen, Martine
Athens, Greece

Analytical performance of novel serum free light chain assays.

19/11/2021
Vercammen, Martine
Brussel

Clinical Decision guidelines for monoclonal gammopathies require an assay specific approach.

19/11/2021
Vercammen, Martine
Brussel

Free light chain antigen excess detection in three polyclonal assays on four analytical platforms.

19/11/2021
Vercammen, Martine
Brussel

Results from the LIME survey ANA methodology. Sciensano symposium. The importance of harmonization in ANA testing. Latest progress of harmonization initiatives.

22/11/2019
Vercammen, Martine
Antwerpen

14th Dresden symposium on autoantibodies. 5th International Consensus on ANA Pattern (ICAP) Workshop 4th International Autoantibody Standardization (IAS) Workshop.

10-13/09/2019
Vercammen, Martine
Dresden

Progress in antigen excess detection.

31/05/2018
Vercammen, Martine
Antwerpen

Total complement activity (CH50): evaluation of thermostability and comparison of 2 liposome based assays OPtilite The Binding Site versus Autokit Wako.

01/01/2018
Vercammen, Martine
Lissabon

Analytical performance of the single well titer function of NOVA View: good enough to omit ANA IIF titer analysis?

01/01/2018
Vercammen, Martine
Lissabon
Back To Top